U.S. market Closed. Opens in 16 hours 49 minutes

ICU | SeaStar Medical Holding Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 7.21 - 7.89
52 Week Range 0.1620 - 42.92
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 155,349
Average Volume 303,528
Shares Outstanding 4,168,970
Market Cap 30,350,102
Sector Healthcare
Industry Biotechnology
IPO Date 2021-03-18
Valuation
Profitability
Growth
Health
P/E Ratio -0.34
Forward P/E Ratio N/A
EPS -21.50
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 12
Country USA
Website ICU
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
*Chart delayed
Analyzing fundamentals for ICU we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ICU Fundamentals page.

Watching at ICU technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ICU Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙